250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 50 Medical Startup Investors in Italy in May 2025

A list of 50 angel investors and VC (Venture Capital) funds that invest in Medical startups based in Italy. We rank investors based on the number of investments they made in Medical companies from Italy. We update this investor list every month.

Top 50 Medical Startup Investors in Italy in May 2025

Investor Medical Italy investments
Italian Angels for Growth 8
CDP Venture Capital 8
Innogest Capital 6
Panakes Partners 5
Invitalia Ventures 4
LIFTT 4
INGENIUM Emilia Romagna 3
Indaco Venture Partners 3
Vertis 3
Principia SGR 2
Luca Trevisan 2
Lumen Ventures 2
Equiter 2
3B Future Health Fund 2
Lazio Innova 2
EASME - EU Executive Agency for SMEs 1
Alchimia Investments 1
Romed 1
Embed Capital 1
Metaventures 1
Index Ventures 1
Growth Engine 1
Sistema Investimenti 1
Evotec 1
RedSeed Ventures 1
Schia Ventures 1
RoboIT 1
Rearden Capital Management LLC 1
Exceptional Ventures 1
Laura Iris Ferro 1
Andera Partners 1
V-Bio Ventures 1
Angelini Ventures 1
Giovanni Leo 1
Launch Tennessee 1
Fountain Healthcare Partners 1
Giovanni Cerutti 1
Fondazione Cottino 1
European Commission 1
Toscana Next Fund 1
ENEA Tech e Biomedical 1
SIMEST 1
Antin Infrastructure Partners 1
P101 1
GCM Group 1
UniCredit 1
a|impact 1
ArchiMed 1
Rancilio Cube 1
Claris Ventures 1
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
Italian Angels for Growth VC Fund · Milan, Lombardia, Italy
IAG is an angel investor network that offers access to its affiliates to early-stage venture opportunities. Its members to date have deployed over 22 million Euros to support 41 startups in the series seed/series A stage in many verticals, among which: Medtech, SAAS, e-commerce, Fintech, and high tech at large. Every investment opportunityat IAG is vetted by a professional team together with expert members of the group. Once invested, the company receives the support of up to two Investment champions, who bring their expertise to the table and help them succeed.
Show more
Investment focus
  • Software, E-Commerce, Health Care
  • Seed, Angel, Series A
  • Italy, United States, United Kingdom
Portfolio highlights
  • ALKemist Bio — ALKemist Bio provides cell treatment to cancer patients.
  • Rubedo Life Sciences — Rubedo Life Sciences is the Premier Longevity Company. Rubedo discovers and develops medicines to keep you biologically young.
  • Restorative Neurotechnologies — Siamo un'azienda di dispositivi medicali certificati per la riabilitazione cognitiva ed il trattamento di disturbi cognitivi post ictus.
CDP Venture Capital VC Fund · Rome, Lazio, Italy · 42 investments in the past 12 months
CDP Venture Capital Sgr - National Innovation Fund aims to make venture capital a cornerstone of the country's economic development and innovation, creating the conditions for an overall and sustainable growth of the venture capital ecosystem.
Show more
Investment focus
  • Software, Health Care, Information Technology
  • Seed, Series A, Funding Round
  • Italy, United States, United Kingdom
Portfolio highlights
  • Tundr — Tundr offers smartcard to companies for sustainable mobility.
  • Genius4U — Genius4U offers washing, sewing, registered mail, shipping, and parcel delivery services. They provide physiotherapist massager, osteopath, nutritionist, hairdresser, beautician, and psychologist services. They also provide professional babysitting services.
  • Iama Therapeutics — At IAMA Therapeutics, we are constantly pushing the boundaries of neuroscience drug discovery to develop new medicines and make a difference in the lives of children suffering from brain disorders and their families. Our purpose is to provide a therapeutic solution to children suffering from neurological conditions and provide their families withthe support they need.
Innogest Capital VC Fund · Milan, Lombardia, Italy
We are investors in companies that make the difference. We partner with hard-working entrepreneurial visionaries
Show more
Investment focus
  • Health Care, Medical, Medical Device
  • Funding Round, Series A, Series B
  • Italy, United States, Spain
Portfolio highlights
  • GreenBone Ortho — GreenBone Ortho was founded in Faenzato offer advanced and innovative solutions in the field of orthopaedics and bone regeneration, using the Rattan wood.
  • Renovacor — Renovacor is a preclinical‑stage biopharmaceutical company focused on developing transformative gene therapy‑based treatments for cardiovascular disease.Renovacor’s lead program is a recombinant adeno-associated virus (AAV)‑based gene therapy for patients suffering from dilated cardiomyopathy (DCM) due to mutations in the Bcl2‑associatedathanogene 3 (BAG3) gene.Dilated cardiomyopathy is a condition affecting over 3 million patients in the US and growing steadily. Many patients develop DCM due to ischemic heart disease. Recently subpopulations have been identified that develop DCM due to mutations in specific genes that have been shown to result in the development of DCM. One of these specific genes is the BAG3 gene. The prevalence of disease‑causing BAG3 haploinsufficiency is estimated at approximately 35,000 individuals in the United States, representing an orphan disease by FDA guidelines. It is estimated a similar number of DCM patients with BAG3 mutations exist in Europe. These patients are typically younger and progress to end-stage heart failure sooner than patients with ischemic heart disease. Currently, DCM patients with a BAG3 mutation are treated with standard of care for heart failure. Despite improvements in pharmacotherapy and care, the five‑year survival of a patient with DCM is only 50%. The development of a BAG3 gene replacement therapy for patients with DCM that carry BAG3 mutations could potentially prevent the progression of disease in this otherwise healthy population of young adults.
  • BetaGlue Technologies — BetaGlue Therapeutics is a life sciences company that delivers radiotherapy from within. Introducing Yntradose, our proprietary product.
Panakes Partners VC Fund · Milano, Lombardia, Italy · 10 investments in the past 12 months
Panakès Partners is a Venture Capital firm, based in Milan, which invests in the most ambitious companies and teams, developing revolutionary technologies and products, in the field of life sciences, aiming to improve the lives of people around the world. Panakès, founded in 2015 by Fabrizio Landi, Alessio Beverina and Diana Saraceni, has 250million under management.
Show more
Investment focus
  • Health Care, Medical, Medical Device
  • Series B, Series A, Series C
  • Italy, Switzerland, United Kingdom
Portfolio highlights
  • DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
  • Relief — RELIEF s.r.l. aims at introducing on the market miniaturized devices for the treatment of urinary incontinence. In particular, the company proposes a technology that is simple, highly innovative, unisex, effective, low-cost and acceptable from the patient viewpoint.
  • Neuromod Devices — Neuromod is a medical device company formed to advance the science of bi-modal neuromodulation.We are committed to delivering treatments that significantly reduce the suffering of underserved patient populations who live with chronic and debilitating conditions globally. Our goal is to design products that empower patients to take control oftheir own treatment, delivering targeted therapies that integrate seamlessly into a modern lifestyle.Neuromod has developed and patented a bi-modal neuromodulation technology that it is evaluating for neurological disorders including chronic tinnitus, a condition affecting 10% of the adult population and commonly known as 'ringing in the ears'.
Invitalia Ventures VC Fund · Rome, Lazio, Italy
Invitalia Ventures SGR manages the “Italia Venture Fund I”, a 87€/Ml sized co-investment fund that invests in early stage operations in Italy. They co-invest up to a maximum of 70% in round A (€ 0.5ML - € 1.5ML) in high growth sectors. Invitalia Ventures, with its network of co-investors not only provides risk capital, but also know-how and anetwork for business development. Main LPs includes the Ministery of Economic Development, the European Investment Bank, Cisco Group, the Sardinian Banking Foundation and Metec Group.They are looking for visionary entrepreneurs who share their passion for innovation. Growth is their mission!!For more information please contact us at info@invitaliaventures.it or visit our website: www.invitaliaventures.it
Show more
Investment focus
  • Software, Medical, Health Care
  • Series A, Funding Round, Seed
  • Italy, United States, United Kingdom
Portfolio highlights
  • Ecomate — The ESG Rating platform for every company
  • BigProfiles — A deep understanding of customers let a company tailor marketing campaigns and CRM strategies, but companies have only basic data about customers (e.g. gender or age). External data sources like Social Networks, Public Registries and Socio-Demographic data contain rich information about billions of people, like job titles, levels of education,interests and habits.BigProfiles is a Customer Intelligence SAAS that leverages external information about persons to enrich customer profiling: it can profile a company's customers with previously unknown information about them. Thanks to its Identity Resolution algorithm (the result of a PHD), it identifies a person’s information scattered among external sources.Through this technology, BigProfiles provides customer base analytics and behavior predictions: using Artificial Intelligence on enriched profiles allows to predict churn, fraud and willingness to buy.
  • Codemotion — Codemotion is the ecosystem devoted to innovation, focused on developers and coding, open to all programming languages and technologies. Pioneering spirits, it scout the future to deliver a first class experience to our people. Codemotion is one of the biggest tech-conferences in Europe, with an international network of 30.000 developers and 350speakers coming from all over the world and from the most important IT realities.Codemotion draw in its main conferences, thousands of attendees eager to discuss about hottest topics: it tailor for them disruptive proposals ranging from mobile to UX, develops, cloud, big data, gamedev, security, methods, languages, web, Internet of things. Codemotion is also a startup, providing a bunch of services and activities, for personal and business customers.
LIFTT VC Fund · Turin, Piemonte, Italy · 7 investments in the past 12 months
A not-only-profit operating investment company, eager to create a bridge between innovative ideas, territory and capital.
Show more
Investment focus
  • Biotechnology, Software, Information Technology
  • Seed, Funding Round, Series A
  • Italy, United Kingdom, France
Portfolio highlights
  • Lumai — Lumai delivers fully optical computing for a quicker, smarter and more sustainable world. Lumai power the revolution of fully optical computing by working at the nexus of photonics and machine learning.
  • Mediaire — mediaire supports radiologists with AI-based tools for MRI reporting. This enables them to make a more accurate and objective assessment even faster.
  • Sparrow Quantum — Sparrow Quantum, a global leader in quantum photonic chip technology. Explore innovative solutions driving advancements in quantum computing, communication, and beyond. Stay ahead with cutting-edge technologies shaping the future.
INGENIUM Emilia Romagna VC Fund
INGENIUM Emilia Romagna was started with EUR 5.30 million by the Emilia Romagna region and EUR 1.7 million from fund managers. Managed by META Investment, the nine-year fund operated through the temporary acquisition of minority stakes in high-opportunity technological companies. It is now fully invested.
Show more
Investment focus
  • Medical, Health Care, Privacy
  • Seed, Angel, Funding Round
  • Italy
Portfolio highlights
  • CellPly — Cellply is a life-science company focused on developing next-generation analytical tools enabling a deep characterization of cancer immunotherapies, cell therapies and cell-based biotherapeutics. The company aims to support the development of novel cancer immunotherapies by accelerating R&D, automating the quality control and advancing theability to monitor the clinical response to these treatments.Through the use of proprietary microfluidic technologies with Co-Culture Array technology, highly-automated analytical instruments and AI-powered image and data analytics, Cellply products define the function of the immune system one cell at a time, combining functional data with other multiplex data and providing unprecedented single-cell analytical solutions.
  • GreenBone Ortho — GreenBone Ortho was founded in Faenzato offer advanced and innovative solutions in the field of orthopaedics and bone regeneration, using the Rattan wood.
  • Angiodroid — Angiodroid srl, a medical technology company, focuses on hemodynamics, vascular surgery, and interventional radiology. It offers an automatic injection system for carbon dioxide angiography. Its products include carbon dioxide injector that is used as a contrast medium for pheriperal interventional angiography; and a single use kit, which iscomposed of French catheters and a custom connection line. The company is based in San Lazzaro di Savena, Italy.
Indaco Venture Partners VC Fund · Milan, Lombardia, Italy · 7 investments in the past 12 months
VENTURE We invest across all sectors with specific focus on technology and digital The largest independent more About Us Portfolio [...]
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • Italy, Switzerland, United States
Portfolio highlights
  • TES Pharma
  • Iama Therapeutics — At IAMA Therapeutics, we are constantly pushing the boundaries of neuroscience drug discovery to develop new medicines and make a difference in the lives of children suffering from brain disorders and their families. Our purpose is to provide a therapeutic solution to children suffering from neurological conditions and provide their families withthe support they need.
  • Valo Therapeutics — Valo Therapeutics is an immunotherapy company that is developing antigen-coated oncolytic viruses as anti-cancer therapeutic vaccines. The Valo Tx platform, PeptiCRAd (Peptide-coated Conditionally Replicating Adenovirus), was developed out of the laboratory of Professor Vincenzo Cerullo at the University of Helsinki. It turns oncolytic adenovirusesinto targeted tissue specific cancer vaccines without the need to generate and manufacture multiple genetically modified viruses. The company is also developing PeptiENV, among other neoantigen strategies, in collaboration with Professor Cerullo. PeptiENV is expected to improve the therapeutic response to enveloped oncolytic viruses in the treatment of multiple forms of cancer.
Vertis VC Fund · Milan, Lombardia, Italy · 4 investments in the past 12 months
Vertis is a dynamic and independent investment management company authorised by Bank of Italy. It manages five closed-end funds for qualified investors by participating in research projects, spin-offs, startups and PMI and deals with the investments of the innovative Made in Italy.
Show more
Investment focus
  • Software, Health Care, Biotechnology
  • Seed, Series A, Funding Round
  • Italy, United States
Portfolio highlights
  • Radical Storage — Find your closest luggage storage and enjoy your journey until the very end!
  • Focoos AI — Focoos reshapes computer vision with ultra-efficient models that drive down costs, automate hardware integration, and ensure peak performance on any device, while promoting sustainability.
  • TimeFlow — TimeFlow is a software that acts as a B2B marketplace dedicated to the technical and managerial consulting sector.
Principia SGR VC Fund · Milan, Lombardia, Italy
Principia is an Italian Venture Capital firm with over Eur 80M under management. Currently Principia has two funds investing in digital start ups and expansion capital opportunities and in particular cases, we invest also in seed opportunities.
Show more
Investment focus
  • Health Care, Biotechnology, Software
  • Funding Round, Series A, Seed
  • Italy, United States, United Kingdom
Portfolio highlights
  • KLISBio — KLISBio is a medtech company currently developing a variety of regenerative medicine implantable products leveraging the power of silk fibroin to promote an endogenous repair of human soft tissues.
  • ENTEROME — We are a clinical stage biopharmaceutical company developing novel drugs to transform human health based on our unique ability to de-code molecular interactions in the gut microbiome.
  • WISE — WISE (Wiringless Implantable Stretchable Electronics) is a start-up company created in 2011 with the mission of producing the new generation of leads for neuromodulation for treatment of chronic pain and Parkinson: unbreakable, less invasive and cheaper.
Luca Trevisan Angel · Siena, Toscana, Italy
Luca Trevisan Sales Manager and Business Coordinator.
Show more
Investment focus
  • Medical, Health Care, Medical Device
  • Series A
  • Italy
Portfolio highlights
  • I-VASC — I-VASC has developed the VELEX device using new technology to treat CVI and varicose veins.
Lumen Ventures VC Fund · London, England, United Kingdom
Lumen Ventures is a venture capital firm that focuses on seed investments, early-stage investments, and private equity.
Show more
Investment focus
  • B2B, E-Commerce, Food and Beverage
  • Seed, Pre-Seed, Series A
  • Italy
Portfolio highlights
  • GenomeUp — GenomeUp is an AI platform (SaaS) to enabling doctors and clinical institutions to diagnose and treat rare genetic diseases in less than 24h. GenomeUp is involved in international research projects and clinical trials in partnership with universities and research centers.
  • Insoore — Insoore is a platform that helps insurance companies to improve the claims management process, thanks to on-demand photographic inspections and damage estimates provided by a community of experts.
  • Carol — Carol is a tech-enabled healthcare provider delivering membership-based primary care services, on a mission to make high-quality healthcare accessible and affordable for everyone. To achieve this goal, Carol leverages a highly scalable technology, combined with high quality clinical operations and a salaried provider model.
Equiter VC Fund · Turin, Piemonte, Italy
Equiter seleziona, realizza e gestisce investimenti infrastrutturali in capitale di rischio finalizzati allo sviluppo socio-economico del territorio.
Show more
Investment focus
  • Medical, Health Care, Information Technology
  • Seed, Series B, Convertible Note
  • Italy
Portfolio highlights
  • AWorld — AWorld is The Sustainability Platform and Mobile App chosen by the United Nations to support the ActNow Campaign.
  • Medics — 3D anatomical modeling per la pianificazione pre-operatoria e il supporto intra-operatorio delle chirurgie complesse.
  • BionIT Labs — We apply IT to Bionics in order to Turn disabilities into New Possibilities
3B Future Health Fund VC Fund · Monaco, Bayern, Germany
Helsinn Investment Fund S.A. is a Luxembourg fund focused on early-stage investments in areas of high unmet patient need.
Show more
Investment focus
  • Biotechnology, Therapeutics, Medical
  • Series B, Series A, Funding Round
  • United States, Italy, United Kingdom
Portfolio highlights
  • NeoPhore — NeoPhore targets the dynamics of cancer neoantigen evolution and makes effective medicines that will become a key part of the next-generation of cancer immunotherapies.
  • Fore Biotherapeutics — We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics.
  • On Target Laboratories — ON TARGET LABORATORIES discovers and develops fluorescent markers to target and illuminate cancer during surgery so it can be removed more completely.
Lazio Innova VC Fund · Rome, Lazio, Italy
Lazio Innova is a venture capital firm with its headquarters in Rome in Italy. The firm provides services in areas such as credit support and guarantees, interventions in risk capital, internationalization services, promotion of business networks and services for the creation and enterprise development.
Show more
Investment focus
  • Software, Health Care, Artificial Intelligence
  • Seed, Pre-Seed, Grant
  • Italy, United Kingdom
Portfolio highlights
  • Joinrs — We developed an artificial intelligence model able to read job offers for you and show you the ones that best match your profile.
  • Medicud — Medicud develops a device for treating wounds with negative pressure dressing.
  • Ticketoo — Ticketoo: compra e vendi biglietti fan-to-fan in modo sicuro
EASME - EU Executive Agency for SMEs VC Fund · Brussels, Brussels Hoofdstedelijk Gewest, Belgium
Executive Agency for SMEs
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Grant, Seed, Funding Round
  • Spain, Switzerland, United Kingdom
Portfolio highlights
  • AGADE — AGADE specialising in robotic exoskeletons. The company created its first product, AGADEXO, which can significantly reduce muscle fatigue and the risk of injury associated with repetitive and dynamic activities. They provide variable support, eliminating the effect of gravity on human limbs and allowing movements comparable to those possible in azero-g environment.
  • BroadBit Batteries — BroadBit is a technology company developing revolutionary new batteries using novel sodium-based chemistries to power the future green economy.
  • Aenitis Technologies — We develop innovative devices for cells therapy processing using Acoustic Radiation Forces.
Alchimia Investments VC Fund · Rome, Lazio, Italy
Alchimia is an investment company primarily operating in the Venture Capital Sector. Leveraging the expertise of our team and a wide network of international advisors, we invest and co-invest in high growth potential opportunities offering capital, as well as dedicated strategic and operational resources.
Show more
Investment focus
  • Health Care, Medical, Artificial Intelligence
  • Series A, Seed, Funding Round
  • Italy, United Kingdom, Israel
Portfolio highlights
  • NoTraffic — NoTraffic has developed the first AI-powered traffic signal platform that connects road...
  • Prestatech — Prestatech is a digital credit factory that has developed an innovative underwriting platform for banks and financial institutions in Europe. Currently active with major European banks, Prestatech offers them a variety of digital credit services from data enrichment to end-to-end instant lending solutions. Thanks to technological innovation,Prestatech has gained an extensive expertise in the digital credit space and through its open-platform is currently offering API-based solutions that leverage on AI, advanced algorithms and Big Data technologies.
  • Chiara Ferragni — COM Chiara Ferragni
Romed VC Fund
Romed is an investment firm.
Show more
Investment focus
  • Medical, Wellness, Health Care
  • Funding Round
  • Italy
Portfolio highlights
  • BetaGlue Technologies — BetaGlue Therapeutics is a life sciences company that delivers radiotherapy from within. Introducing Yntradose, our proprietary product.
Embed Capital VC Fund · Milan, Lombardia, Italy
Embed Capital directly invests in startups, established or in the process of creation.Embed is mainly focused on innovative companies that:- Are active in the so-called “real economy” sectors: industrials, technology, environment, services, retail or social;- Are characterized by simple and intuitive business models and valuepropositions, and operate in markets or market segments featuring high growth potential;- Present a clear competitive advantage and high barriers-to-entry;- Are cash-generative in the medium term.Given that Embed Capital is not a closed-end fund, it doesn’t have specific time-constrains and it can assess on a project-by-project basis to determine the best time to sell a participation, and sign customized agreements with the entrepreneurs.
Show more
Investment focus
  • Information Technology, Health Care, Mobile
  • Seed, Funding Round, Pre-Seed
  • Italy, Switzerland, United Kingdom
Portfolio highlights
  • Piantando — Piantando sells plants connected to initiatives for the preservation of the planet engaged in the following areas: land, water, climate, biodiversity and local communities. Each plant is equivalent to a transparent and unique contribution, destined to an initiative certified by our Value Chain. Everyone become ambassadors of a new way of livinggreen and understanding their commitment to the planet.
  • FrescoFrigo - Healthy food close to you — FrescoFRIGO is a smart fridge with fresh and quality products designed for the needs of worker. Improve everyday lifestyle, through automated proximity selling of good, fresh and healthy product, innovating technology and user experience.
  • The Nemesis — The Nemesis is the Metaverse for the mass market: virtual worlds, adventures, gaming Play & Earn and amazing experiences.
Metaventures VC Fund · Leeds, Leeds, United Kingdom
We invest in the Metaverse
Show more
Investment focus
  • Gaming, Medical, PC Games
  • Funding Round
  • Italy, Brazil, United Kingdom
Portfolio highlights
  • 4MDG — 4MDG focuses on providing various data management services such as registration portal, retail technology and customer registration.
  • Dubit — Choose your path in the Metaverse.
  • CellPly — Cellply is a life-science company focused on developing next-generation analytical tools enabling a deep characterization of cancer immunotherapies, cell therapies and cell-based biotherapeutics. The company aims to support the development of novel cancer immunotherapies by accelerating R&D, automating the quality control and advancing theability to monitor the clinical response to these treatments.Through the use of proprietary microfluidic technologies with Co-Culture Array technology, highly-automated analytical instruments and AI-powered image and data analytics, Cellply products define the function of the immune system one cell at a time, combining functional data with other multiplex data and providing unprecedented single-cell analytical solutions.
Index Ventures VC Fund · San Francisco, California, United States · 59 investments in the past 12 months
Index Ventures is an international venture capital firm with dual headquarters in San Francisco and London, investing in technology-enabled companies with a focus on e-commerce, fintech, mobility, gaming, infrastructure/AI, and security.
Show more
Investment focus
  • Software, E-Commerce, Internet
  • Series A, Series B, Seed
  • United States, United Kingdom, France
Portfolio highlights
  • Duna — Meet the modern platform that accelerates business onboarding, automates manual work and grows revenue.
  • Hedra — Video creation for everyone.
  • Persona — Online ID verification service to help any business, from any industry, collect, verify, and manage user identities throughout a customer lifecycle.
Growth Engine VC Fund · Milan, Lombardia, Italy · 5 investments in the past 12 months
Growth Engine is a holding company that invests in startups and scaleups with high growth potential founded by Fabio Mondini de Focatiis, Andrea Marangione, Michele Appendino and Marco Ariello, Venture Capital professionals with an excellent track record. Growth Engine invests in Italian startups at the Pre-Seed and Seed stage.
Show more
Investment focus
  • E-Commerce, Information Technology, Software
  • Seed, Secondary Market, Pre-Seed
  • Italy, Mexico, United Kingdom
Portfolio highlights
  • Cubbit — Cubbit is secure encrypted cloud storage with a difference. A distributed cloud that is 100% private and green. Join the Swarm.
  • TrueScreen — Certify photo, video, screenshot, document and audio recording with legal value. Prevent fraud and disputes obtaining indisputable evidences
  • TimeFlow — TimeFlow is a software that acts as a B2B marketplace dedicated to the technical and managerial consulting sector.
Sistema Investimenti VC Fund · Catania, Sicilia, Italy
Sistema Investimenti is an holding in the form of SpA, established by the will of young professionals and entrepreneurs in Sicily. Sistema Investimenti focus on qualified minorities primarily in companies in the South of Italy with the exception of turnaround/restructuring and distressed.
Show more
Investment focus
  • Mobile, Medical, Health Care
  • Seed
  • Italy
Portfolio highlights
  • Pedius — Pedius is a communication system that allows deaf people to make normal phone calls. Use it in your everyday life to make important calls such as booking doctors appointments or making reservations, or to call family, friends and coworkers.Once you download the smartphone app you can start a conversation by either typing or speaking a message.The recipient will listen on their end and reply, and you will immediately read a transcription of what he or she just said. Pedius gives you the freedom to have real-time conversations when you need to call a plumber, book a table at your favourite restaurant, or talk to your doctor.The Pedius app is especially useful when you need to contact someone accessible only by phone, and it is an excellent help when you need to be careful about your privacy.
  • Angiodroid — Angiodroid srl, a medical technology company, focuses on hemodynamics, vascular surgery, and interventional radiology. It offers an automatic injection system for carbon dioxide angiography. Its products include carbon dioxide injector that is used as a contrast medium for pheriperal interventional angiography; and a single use kit, which iscomposed of French catheters and a custom connection line. The company is based in San Lazzaro di Savena, Italy.
Evotec VC Fund · Hamburg, Hamburg, Germany
Evotec is a global biotechnology company committed to advancing drug discovery & development together with our partners for medicines that matter.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Seed
  • United States, Germany, France
Portfolio highlights
  • Aptadir Therapeutics — Reprogramming DNA methylation in disease conditions by RNA therapeutics APTADIR Contact us NEWS Press Release Reprogramming DNA methylation by RNA therapeutics A novel therapeutic approach for untreatable cancers and rare diseases Aberrant methylation by DNA methyltransferase 1 (DNMT1) of certain genes may cause abnormal cell development and lead to disease. Current therapies targeted to inhibit
  • Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and
  • Aeovian Pharmaceuticals — Aeovian is a San Francisco based biopharmaceutical company developing novel and highly selective therapeutics modulating mTORC1 pathway.
RedSeed Ventures VC Fund · Milano, Lombardia, Italy
RedSeed Ventures is a Venture Capital firm investing in Early Stage Companies and Scaleups, in Europe and more particularly in Italy.
Show more
Investment focus
  • Retail, Crowdsourcing, Information Technology
  • Seed, Series A
  • Italy, United Kingdom
Portfolio highlights
  • Dianax — Milan-based Dianax was founded in 2013 starting from a group scientists led by Eugenio Iannone and Maurizio Moroni and by a few angel investors orchestrated by Gabriele Bavagnoli. Dianax mission is to develop and manufacture labs-on-chip aiming to trasform protein-based diagnostics and make it prompt, easy to use, inexpensive and reliableTheDianax novel technology is designed to make precise diagnostic results convenient, easily accessible, and affordable to patients and healthcare professionals, to empower them to effective prevention, ongoing accurate management and timely emergency treatment.The Dianax technology is the first ever application to diagnostics of a combination of microfluidic innovations and electrochemistry detection systems.Dianax was founded by Eugenio Iannone and his partners to pursue technical and market opportunities based on proprietary, independent research.
  • Leaf Space — Leaf Space aims to become a global leading service provider in the new, emerging microsatellite market by developing a technology platform providing all basic services required by microsatellite operators.
  • WIB Machines — Smart vending machines and smart lockers manufacturer pioneering smart, web-based retail automation globally. Patented solutions enabling next-gen retail.
Schia Ventures VC Fund
Schia Ventures is investment firm.
Show more
Investment focus
  • Medical, Health Care, Biotechnology
  • Funding Round
  • Italy
Portfolio highlights
  • CellPly — Cellply is a life-science company focused on developing next-generation analytical tools enabling a deep characterization of cancer immunotherapies, cell therapies and cell-based biotherapeutics. The company aims to support the development of novel cancer immunotherapies by accelerating R&D, automating the quality control and advancing theability to monitor the clinical response to these treatments.Through the use of proprietary microfluidic technologies with Co-Culture Array technology, highly-automated analytical instruments and AI-powered image and data analytics, Cellply products define the function of the immune system one cell at a time, combining functional data with other multiplex data and providing unprecedented single-cell analytical solutions.
RoboIT VC Fund · 2 investments in the past 12 months
RoboIT is the National Technology Transfer Hub for Robotics and Industrial Automation.
Show more
Investment focus
  • Medical, Manufacturing, Medical Device
  • Pre-Seed
  • Italy
Portfolio highlights
  • J4Energy — J4ENERGY is a digital energy platform that uses "Energy Co-Pilot" technology to assist industrial decision-makers in decarbonisation processes. The platform reduces costs and emissions by over 50% at various plants, aims to accelerate the energy transition in the industrial sector.
  • Eye2Drive — EYE2DRIVE is a young company designing and building a new imaging sensor for the autonomous cars. We are based in Tuscany, Italy.
  • Fluid Wire Robotics — Fluid Wire Robotics sets the new standard for robots in harsh environments. We design innovative robotic arms that excel in radioactive, explosive, space, and subsea applications, avoiding the complexity and cost of traditional solutions. Our technology ensures unparalleled safety, reliability, and efficiency, redefining robot design for any challenging environment without performance loss. Discover our groundbreaking approach and robust, versatile solutions.
Rearden Capital Management LLC VC Fund
Rearden Capital is a trading and investment firm managing proprietary capital across commodity, currency, fixed income and equity asset classes and related derivative instruments in the global markets.
Show more
Investment focus
  • Medical, Health Care, Biotechnology
  • Funding Round
  • Italy
Portfolio highlights
  • CellPly — Cellply is a life-science company focused on developing next-generation analytical tools enabling a deep characterization of cancer immunotherapies, cell therapies and cell-based biotherapeutics. The company aims to support the development of novel cancer immunotherapies by accelerating R&D, automating the quality control and advancing theability to monitor the clinical response to these treatments.Through the use of proprietary microfluidic technologies with Co-Culture Array technology, highly-automated analytical instruments and AI-powered image and data analytics, Cellply products define the function of the immune system one cell at a time, combining functional data with other multiplex data and providing unprecedented single-cell analytical solutions.
Exceptional Ventures VC Fund · London, England, United Kingdom · 4 investments in the past 12 months
Exceptional Ventures is an early-stage venture capital firm that invests in entrepreneurs and businesses that improve people's lives. Founded in 2022 and is based in London, England.
Show more
Investment focus
  • Health Care, Food and Beverage, Biotechnology
  • Convertible Note, Seed, Pre-Seed
  • United Kingdom, Italy, France
Portfolio highlights
  • Circe — Circe grows their food through fermentation. Using the right fats they make food people want to eat and use CO2 as a feedstock to scale production in an economically viable and climate-friendly way.
  • ReportAId — ReportAId is an AI-powered software that breathes life into medical reports to make healthcare more organized, customized, and accessible.
  • Jove Insurance — Jove provides business and protection insurance to contractors, freelancers and SMEs, powered by tech and driven by social good.
Laura Iris Ferro Angel · Milan, Lombardia, Italy
Laura Iris Ferro
Show more
Investment focus
  • Health Care, Biotechnology, Medical Device
  • Pre-Seed, Funding Round
  • Italy
Portfolio highlights
  • Newronika — Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normaldaily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. ​ Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.
  • Bio4Dreams — Il primo incubatore italiano certificato di startup innovative in fase very early stage, a capitale totalmente privato, dedicato alle Scienze della Vita.
Andera Partners VC Fund · Paris, Ile-de-France, France · 11 investments in the past 12 months
Andera Partners, formerly known as Edmond de Rothschild Investment Partners (EdRIP) As heir to the traditions and values that have ensured the success of the Rothschild family for 250 years, the Edmond de Rothschild Group has established itself over time as a leading player in European finance. Its activities are grouped around two major areas:Private Banking and Asset Management. The Group offers wealthy families, entrepreneurs, and large institutions a full range of solutions combining a culture of tailored solutions, stability, performance, and innovation. The Edmond de Rothschild Group’s offering is characterised by strong convictions, with the desire to guarantee to each of its customers: A unique, close relationship, underpinned by the know-how and the variety of expertise of a large international group; Autonomous, experienced teams, who anticipate economic trends and innovate to establish long-term performance; The recognised stability, strength, and independence of a family-owned financial group. Founded by Baron Edmond de Rothschild in 1953, the Group has been chaired by his son, Baron Benjamin de Rothschild, since 1997.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series B, Private Equity, Funding Round
  • France, United States, Germany
Portfolio highlights
  • FIRE1 — FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.
  • Evommune — Evommune is taking a tissue-based approach to advance insights and accelerate the development of transformative medicines in inflammatory diseases.
  • Bioptimus — Our mission is to build the first universal AI foundation model for biology to fuel breakthrough discoveries and accelerate innovations in biomedicine and beyond.
V-Bio Ventures VC Fund · Gent, Oost-Vlaanderen, Belgium · 4 investments in the past 12 months
V-Bio Ventures is an independent venture capital firm specialized in building and financing young, innovative life science companies. The fund invests throughout Europe in start-up and early-stage companies with high growth potential focusing on technologies that provide transformational improvements in the biotech, pharmaceutical and agriculturalsectors.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Series B, Seed
  • Belgium, France, United Kingdom
Portfolio highlights
  • Avidicure — Avidicure is developing dual agonistic avidity-engineered multifunctional antibodies, AVC-Boosters, as monotherapy for treatment of cancer
  • ATB Therapeutics — ATB Therapeutics is a biopharmaceutical company that provides novel therapeutic solutions and treatments for cancer patients.
  • Confo Therapeutics — Confo Therapeutics is a clinical-stage company committed to accelerating novel GPCR-directed medicines for metabolic & endocrine diseases.
Angelini Ventures VC Fund · Rome, Lazio, Italy · 7 investments in the past 12 months
Angelini Ventures is an investment firm.
Show more
Investment focus
  • Health Care, Therapeutics, Biotechnology
  • Series A, Series B, Series C
  • United States, Italy, Belgium
Portfolio highlights
  • Vantis — Vantis GmbH is a Digital solution for Chronic cardiovascular diseases that requires personalized ongoing treatment for decades.
  • Biovitae — Benvenuto sul sito ufficiale di Biovitae, la tecnologia italiana brevettata per la sanificazione degli ambienti.
  • Nuevocor — Nuevocor is a preclinical-stage biopharmaceutical company focused on developing gene therapy‑based treatments that have the potential to restore cardiac function in diseased hearts.
Giovanni Leo Angel · Geneva, Geneve, Switzerland
Giovanni Leo is the Partner at Efficient Frontier Investing.
Show more
Investment focus
  • Health Care, Medical Device, Medical
  • Seed, Series B
  • Switzerland, Italy
Portfolio highlights
  • Medyria — Medyria is a Swiss medtech startup that engineers technologies for cardiovascular catheter navigation and sensing. They develop a unique guiding and sensing medical device based on proprietary Blood Flow Velocity Sensor technology. The TrackCath System is designed to be cost-effective and safe during EVAR procedures.Medyria's goal is todevelop devices that enable safer and more effective endovascular procedures. It was founded in 2014 and is based in Winterthur, Zurich, Switzerland.
  • Terapet — Terapet was founded at CERN by two physicists – Christina Vallgren and Marcus Palm – along with Professor Raymond Miralbell from the Geneva University Hospitals (HUG). They have already proven the feasibility of their concept and are now developing an initial version for market launch.
  • CV Lab — CV Lab is the first incubator fully focused on cardiovascular innovation in Europe. It supports the most promising ideas through patenting, prototyping, and proof of concept until they mature enough to give life to a spin-off and meet international capitals. CVLab puts to good use the experience of entrepreneurs and specialists with strongexpertise in biomedical. The company collaborates with experts in the field. CVLab is a lean organization, close to researchers and clinical needs.
Launch Tennessee VC Fund · Nashville, Tennessee, United States
Launch Tennessee provides startup resources to entrepreneurs, including capital sources, mentorship, accelerators, entrepreneurship training and more
Show more
Investment focus
  • Software, Health Care, Medical
  • Grant, Seed, Series A
  • United States, China, Italy
Portfolio highlights
  • DAXOR — DAXOR Corporation is an innovative medical instrumentation and biotechnology company. DAXOR designed and developed the BVA-100 Blood Volume Analyzer. It is the first instrument approved by the FDA to provide rapid direct measurement of a patient's true blood volume. We believe that the BVA-100 Blood Volume Analyzer has the potential totransform therapy in a broad range of surgical and medical conditions. It is our goal, working in conjunction with hospitals and clinics, to achieve that possibility.The BVA-100 is a semi-automated Blood Volume Analyzer. It is used in conjunction with a single use diagnostic kit. It is the first FDA-approved instrument to provide rapid direct measurement of a patient's blood volume.
  • Preteckt — Preteckt's AI software predicts & prevents breakdowns in buses & coaches. Reduce costs, maximize uptime, & extend vehicle life
  • Daily Crunch — Daily Crunch is an offline and online store that offers cherry-berry nuts, cacao sea salt, and sprouted almonds products.
Fountain Healthcare Partners VC Fund · Dublin, Dublin, Ireland · 3 investments in the past 12 months
Fountain Healthcare Partners is an Irish based life science venture capital fund. Fountain is exclusively focused on the life science sector. Specific areas of interest to them are: specialty pharma, medical devices, biotechnology and diagnostics. They will deploy the majority of their capital in Europe with a strong focus on Ireland.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series A, Series B, Series C
  • Ireland, United States, France
Portfolio highlights
  • MMI — The future of Microsurgery: microinstruments that expand the possibilities of surgical interventions. Wristed robotic microinstruments for unprecedented results in microsurgery.
  • Mainstay Medical — Mainstay Medical is improving quality of life for patients with chronic low back pain through innovative restorative treatment medical device solutions.
  • XyloCor Therapeutics — XyloCor Therapeutics is a bio-pharmaceutical company intended to develop gene therapy for people with advanced coronary artery disease. The company's service focuses on developing gene therapy to stimulate the formation of new coronary blood vessels and serve areas of the heart that are not receiving adequate blood supply, enabling patientswith refractory angina who exhausted pharmacologic options to cure their cardiovascular diseases painlessly and cost effectively.
Giovanni Cerutti Angel · Milan, Lombardia, Italy
Giovanni Cerutti is a chief executive officer & managing director at NOVAICOS.
Show more
Investment focus
  • Medical, Wellness, Health Care
  • Funding Round
  • Italy
Portfolio highlights
  • BetaGlue Technologies — BetaGlue Therapeutics is a life sciences company that delivers radiotherapy from within. Introducing Yntradose, our proprietary product.
Fondazione Cottino VC Fund
Fondazione Cottino is support young people in their educational path and support for scientific research, technology transfer.
Show more
Investment focus
  • Medical, mHealth, Diabetes
  • Seed
  • Italy
Portfolio highlights
  • D-EYE — D-EYE's technology enables healthcare professionals all over the world to quickly screen for problems, photograph them and then distribute them digitally via various secure wireless solutions. They design and manufacture diagnostic instruments.
European Commission VC Fund · Brussels, Brussels Hoofdstedelijk Gewest, Belgium · 33 investments in the past 12 months
The official website of the European Commission, providing access to information about its political priorities, policies and services
Show more
Investment focus
  • Software, Biotechnology, Health Care
  • Grant, Seed, Pre-Seed
  • Spain, France, Germany
Portfolio highlights
  • ENZIDIA — We crack the fundamental bottlenecks of enzyme engineering with unprecedented screening and data collection capacity
  • ETHRIS — About Ethris Ethris has paved a new path from genes to therapeutic proteins using its proprietary, non-immunogenic messenger RNA technology platform to discover, design and develop innovative therapies. With more than a
  • PhotonHub Europe — PhotonHub Europe is an digital innovation hub for photonics.
Toscana Next Fund VC Fund · Rome, Lazio, Italy · 3 investments in the past 12 months
Toscana Next Fund is a co-investment fund managed by CDP Venture Capital.
Show more
Investment focus
  • Medical, Manufacturing, Medical Device
  • Pre-Seed
  • Italy
Portfolio highlights
  • Eye2Drive — EYE2DRIVE is a young company designing and building a new imaging sensor for the autonomous cars. We are based in Tuscany, Italy.
  • Valuematic — Valuematic realizza soluzioni per il trattamento e gestione dei dati favorendo il miglioramento nei processi organizzativi e informativi di aziende ed enti.
  • Next Generation Robotics — Next Generation Robotics is a company that manufactures robotic systems for inspection and monitoring for the railway industry.
ENEA Tech e Biomedical VC Fund · Rome, Lazio, Italy · 6 investments in the past 12 months
ENEA Tech e Biomedical is a private foundation. It seeks to encourage the strengthening of research, development, and industrial reconversion of the biomedical sector.
Show more
Investment focus
  • Medical Device, Health Care, Biotechnology
  • Series A, Funding Round, Grant
  • Italy, Finland
Portfolio highlights
  • Newronika — Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normaldaily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. ​ Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.
  • Approxima — Approxima medical is developing a novel treatment for patients with tricuspid valve regurgitation
  • Valo Therapeutics — Valo Therapeutics is an immunotherapy company that is developing antigen-coated oncolytic viruses as anti-cancer therapeutic vaccines. The Valo Tx platform, PeptiCRAd (Peptide-coated Conditionally Replicating Adenovirus), was developed out of the laboratory of Professor Vincenzo Cerullo at the University of Helsinki. It turns oncolytic adenovirusesinto targeted tissue specific cancer vaccines without the need to generate and manufacture multiple genetically modified viruses. The company is also developing PeptiENV, among other neoantigen strategies, in collaboration with Professor Cerullo. PeptiENV is expected to improve the therapeutic response to enveloped oncolytic viruses in the treatment of multiple forms of cancer.
SIMEST VC Fund · Rome, Lazio, Italy · 3 investments in the past 12 months
SIMEST is a financial firm focused on the development and promotion of Italian enterprises abroad. Simest acquires up to 49% of the equity capital of foreign firms in countries outside the European Union, whether wholly-owned by Italian companies or set up as joint ventures with local partners. It also provides start-up and growth capital financingas well as participating in buyouts.Geographically it invests in non-EU countries, focusing on BRIC, Americas and Middle-East. Simest also provides Italian companies seeking to internationalize their businesses with technical assistance and advisory services.Simest is a member of the European Development Finance Institutions (EDFI) and the Italian Venture Capital and Private Equity Association (AIFI).
Show more
Investment focus
  • Manufacturing, Coffee, Aerospace
  • Grant, Series A, Series B
  • Italy
Portfolio highlights
  • hlpy — hlpy operates as a roadside assistance company. Hlpy provides a digital roadside assistance service via a network of 580+ centers, 1,900+ drivers/mechanics, 2,800+ tow trucks.
  • Objectway — Powered by over 30 years of business expertise in delivering wealth and asset management technology and services, Objectway empowers its clients to embrace their future challenges while providing great performance today.Objectway solutions and services enable opti-channel customer engagement, front-office productivity, stronger investmentperformance, suitable advice and compliance enforcement, efficient back-office operations and automation, pro-active client reporting and management analytics.Our front-to-back, multi-channel, scalable, cloud-ready platform leverages a component-based architecture with AI-driven algorithmic engines for risk & performance analytics, real-time investment compliance, portfolios optimisation and mass customisation, with open APIs for easy integration.Objectway is a Global Top 100 fintech provider (IDC ranking) and our clients include 200+ leading wealth managers, banks, asset managers, fund managers, insurers and outsourcing providers in more than 15 countries. We support approximately 100,000 investment professionals to manage more than £1 trillion in assets.Objectway operates from offices in Italy, UK, Ireland and Belgium serving customers in 4 continents.
  • BionIT Labs — We apply IT to Bionics in order to Turn disabilities into New Possibilities
Antin Infrastructure Partners VC Fund · Paris, Ile-de-France, France
Antin Infrastructure Partners is a leading private equity firm focused on infrastructure investments.
Show more
Investment focus
  • Energy, Renewable Energy, Beauty
  • Private Equity, Funding Round, Seed
  • Italy, United States, Spain
Portfolio highlights
  • Power Dot — Power Dot is a public EV destination charging infrastructure operator that invests, installs and operates charge points on everyday high-traffic public locations
  • Empire Access — Visit our homepage and read about whatever you need. If you have questions, we have answers.
  • Powerdot — Learn more about Powedot, a company shaping the future of sustainable mobility. Discover our mission, values, goals and much more!
P101 VC Fund · Milan, Lombardia, Italy · 3 investments in the past 12 months
P101 is an Italian venture capital firm focused on early-stage investments in the digital sector. Agreement to handle personal data I agree I don't agree
Show more
Investment focus
  • Software, E-Commerce, Information Technology
  • Funding Round, Seed, Series A
  • Italy, Spain, United States
Portfolio highlights
  • Mundimoto — Mundimoto is a motor cycle trading platform.
  • Carol — Carol is a tech-enabled healthcare provider delivering membership-based primary care services, on a mission to make high-quality healthcare accessible and affordable for everyone. To achieve this goal, Carol leverages a highly scalable technology, combined with high quality clinical operations and a salaried provider model.
  • Cyber Guru — Cyber Guru operates as a cybersecurity awareness training platform. Cyber Guru serves to educate employees around the dangers and pitfalls of information security. The solutions use stimulating and educational learning paths to cater to those who do not hold specialist roles in the field of Cyber Security.
GCM Group VC Fund · Jakarta, Jakarta Raya, Indonesia
GCM Group is an investment firm.
Show more
Investment focus
  • Medical, Health Care, Biotechnology
  • Seed
  • Italy
Portfolio highlights
  • GenomeUp — GenomeUp is an AI platform (SaaS) to enabling doctors and clinical institutions to diagnose and treat rare genetic diseases in less than 24h. GenomeUp is involved in international research projects and clinical trials in partnership with universities and research centers.
UniCredit VC Fund · Milan, Lombardia, Italy · 8 investments in the past 12 months
UniCredit Group is an Italian global banking and financial services company. Its network spanning 50 markets in 20 countries, with more than 9,000 branches and over 148,000 employees. Its strategic position in Western and Eastern Europe gives the group one of the region's highest market shares.
Show more
Investment focus
  • Energy, Software, Financial Services
  • Debt Financing, Post-IPO Debt, Funding Round
  • Italy, Germany, Sweden
Portfolio highlights
  • Edison Spa — Edison is Europe's oldest energy company, and one of the industry leaders in Italy and Europe. Discover all the activities we ar
  • Goglio Group — Goglio Group produces full trademark food packaging.
  • Casalasco Società Agricola — Casalasco Società Agricola is the supply network for the cultivation and processing of industrial tomatoes.
a|impact VC Fund
a|impact invests in the prevailing form of equity or quasi-equity, focusing our operations mainly on companies.
Show more
Investment focus
  • Medical, Health Care, Biotechnology
  • Seed
  • Italy
Portfolio highlights
  • GenomeUp — GenomeUp is an AI platform (SaaS) to enabling doctors and clinical institutions to diagnose and treat rare genetic diseases in less than 24h. GenomeUp is involved in international research projects and clinical trials in partnership with universities and research centers.
ArchiMed VC Fund · Lyon, Rhone-Alpes, France
ArchiMed is an independent group with funds provided by the team as well as European and American investors, both institutional and private (including a number of successful healthcare entrepreneurs).
Show more
Investment focus
  • Health Care, Manufacturing, Pharmaceutical
  • Funding Round, Private Equity
  • Italy, Canada, France
Portfolio highlights
  • Clean Cells — Clean Cells is your reliable CMO/CRO for cell and virus banks manufacturing with a strong expertise in Quality Control Testing for all kind of Bioproducts from R&D to market and in compliance with worldwide regulatory agencies.
  • PlasmidFactory — PlasmidFactory is the leading contract manufacturer and service provider for plasmid DNA and minicircle DNA, custom DNA, In-Stock DNA for AAV and clinical application
  • Corealis Pharma — Corealis Pharma provides services on a contract basis in the areas of formulation and process development as well as in small-scale clinical trial material manufacturing and the packaging of solid dosage forms to pharmaceutical and biotech companies. Its services include API characterization, salt selection, pre-formulation, formulation and processdevelopment, analytical method development, stability storage, and testing, technical transfer and scale-up, cGMP manufacturing and packaging of phase I and II CTM, and dossier support.
Rancilio Cube VC Fund · Milano, Lombardia, Italy
Cube is the investment office founded by Rancilio family
Show more
Investment focus
  • E-Commerce, Software, Financial Services
  • Seed, Series A, Series B
  • United States, Italy, Germany
Portfolio highlights
  • Convoy — Convoy uses technology to make freight more efficient, reduce shippers' costs, increase carriers' earnings, and eliminate carbon emissions.
  • FinCompare - Smarter Business Finance — FinCompare was founded by Stephan Heller and is a fintech startup that helps businesses to find, compare, and close the financing solutions. Via the online platform, companies can access a wide range of financing options. They can independently compare offers from well-known banks, fintechs, and alternative financial services providers in Germanyand close the financing. The company also offers a convenient one-stop destination for all financing questions relating to the company.FinCompare financing solutions including corporate loan, factoring, company leasing/hire purchase, warehouse financing, fine trading/purchase financing, and mezzanine capital. It simplifies the financing process with its digital application process and can thus provide your company financing. The company allows SMEs to receive and compare various offers for loans.FinCompare was founded in October 2016 by Stephan Heller and is headquartered in Berlin, Germany.
  • Finom — Finom combines digital business account benefits with multiple services to provide financial solutions for entrepreneurs, self-employed, and freelancers. It pulls together accounting, financial management, and banking functions for early-stage businesses and SMEs into one mobile-first product.Founded in 2019, Finom is headquartered in Amsterdam,The Netherlands.
Claris Ventures VC Fund · Torino, Piemonte, Italy
Claris Ventures is a venture capital firm supporting the best scientists in building successful life sciences companies that will impact people's lives
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Seed, Series A, Series B
  • Italy, United Kingdom
Portfolio highlights
  • NeoPhore — NeoPhore targets the dynamics of cancer neoantigen evolution and makes effective medicines that will become a key part of the next-generation of cancer immunotherapies.
  • ALKemist Bio — ALKemist Bio provides cell treatment to cancer patients.
  • Iama Therapeutics — At IAMA Therapeutics, we are constantly pushing the boundaries of neuroscience drug discovery to develop new medicines and make a difference in the lives of children suffering from brain disorders and their families. Our purpose is to provide a therapeutic solution to children suffering from neurological conditions and provide their families withthe support they need.
Investors by industry
Investors by country
Investors in Italy by industry